Erectile Dysfunction Drugs Market Is Likely to Plummet in the Near Future to US$3.4 Billion in 2019
The global erectile dysfunction drugs market will decline in the coming few years due to the growing threat of counterfeit drugs. Expiration of patents of many blockbuster drugs will further impede the growth of the global ED drugs market. The global erectile dysfunction drugs market will also be suppressed by the narrowing of insurance coverage for erectile dysfunction treatment. The rising prevalence of sexually transmitted diseases among ED drug users will further challenge the market. On the other hand, factors...
View full press release